Participant-centric Trial Will Test if Antiviral Paxlovid Can Help With Long COVID

Researchers are still in the dark on the mechanisms underlying and how to treat long COVID. A new clinical trial using the oral antiviral Paxlovid will provide

Related Keywords

Akiko Iwasaki ,Haroldh Hines Jr ,Harlan Krumholz ,Hugo Health ,Institute For ,Policy Studies ,Sterling Professor ,Persistence Is One ,Several Long ,Accessible Design ,Professor Krumholz ,Professor Iwasaki ,